Eslicarbazepine acetate loperidone The MPC inhibitor UK5099 increases

The MPC inhibitor UK5099 increases the glucose excursion seen during an intraperitoneal glucose tolerance test in C57BLK mice

5 nM for hM3Dq and hM4Di in vitro

+1/p-1/t23-

(1983) Mol Cell Endocrinol 33: 69-80

Dizocilpine is the most frequently used non-competitive NMDA receptor antagonist in animal models to mimic psychosis for experimental purposes

Eslicarbazepine acetate loperidone The MPC inhibitor UK5099 increasesEslicarbazepine acetate is an antiepileptic drug. It is a prodrug which is activated to eslicarbazepine (S licarbazepine), an active metabolite of oxcarbazepine. The European Medicines Agency (EMA) has recommended granting marketing authorization in 2009 for adjunctive therapy for partial onset seizures, with or without secondary generalisation, in adults with epilepsy. (Source: http: en. wikipedia. org wiki Eslicarbazepine_acetate). Product